Skip to content
Screener

Praxis Precision Medicines, Inc. PRAX Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue-
EPS-$3.36Beat by $0.09
EPS estimate-$3.45

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$130.8K
EPS estimate-$3.65

Financials

Q3 2025

Income statement

See full
Revenue--100%
Operating income-$78.4M-37.9%
Net income-$73.9M-42.4%
EPS (diluted)-$3.36-22.2%

Balance sheet

See full
Cash & equivalents$149.9M-11.3%
Total debt$436.0K-73.7%
Total equity$343.5M-10.2%
Total assets$396.4M-4.8%

Cash flow

See full
Operating cash flow-$65.1M-137%
Free cash flow-$65.1M-137%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.12B+9.2%
Enterprise value$966.12M+13.1%
P/S149.5×-487×

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-75.2%+15.3pp
Debt / equity0×0.0×
Current ratio5.2×-5.8×

FAQ

When did Praxis Precision Medicines, Inc. report Q3 2025 earnings?
Praxis Precision Medicines, Inc. (PRAX) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Praxis Precision Medicines, Inc.'s Q3 2025 revenue and EPS?
Praxis Precision Medicines, Inc. reported revenue of - and eps of $-3.36 for Q3 2025.
Did Praxis Precision Medicines, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-3.45 by $0.09.
How did Praxis Precision Medicines, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 100.0% from $302.0K a year earlier and eps declined 22.2% from $-2.75.
Where can I find Praxis Precision Medicines, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001689548-25-000110) and the 10-Q periodic report (0001689548-25-000111) directly on SEC EDGAR. The filing index links above go to sec.gov.